Germline MC1R status influences somatic mutation burden in melanoma
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
The major genetic determinants of cutaneous melanoma risk in the general population are disruptive variants ( R alleles) in the melanocortin 1 receptor ( MC1R ) gene. These alleles are also linked to red hair, freckling, and sun sensitivity, all of which are known melanoma phenotypic risk factors. Here we report that in melanomas and for somatic C>T mutations, a signature linked to sun exposure, the expected single-nucleotide variant count associated with the presence of an R allele is estimated to be 42% (95% CI, 15–76%) higher than that among persons without an R allele. This figure is comparable to the expected mutational burden associated with an additional 21 years of age. We also find significant and similar enrichment of non-C>T mutation classes supporting a role for additional mutagenic processes in melanoma development in individuals carrying R alleles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Melanomas featuring disruptive mutations in MC1R are associated with a 42% increase in UV-signature mutations over those in MC1R wild-type melanomas75.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: PKA-Mediated Phosphorylation of ATR Promotes Recruitment of XPA to UV-Induced DNA Damage
Jarrett, S. G., Horrell, E. M. W., Christian, P. A., Vanover, J. C., Boulanger, M. C., Zou, Y., & D’Orazio, J. A. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.030 · Cited by 85
Retractedmice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Self-citationSIFT: predicting amino acid changes that affect protein function
Ng, P. C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg509 · Cited by 6,577
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E. S., & Getz, G. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,981
Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2
Adzhubei, I., Jordan, D. M., & Sunyaev, S. R. (2013) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0720s76 · Cited by 3,705
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Forbes, S. A., Beare, D., Gunasekaran, P., Leung, K., Bindal, N., Boutselakis, H., Ding, M., Bamford, S., Cole, C., Ward, S., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1075 · Cited by 2,283
Hierarchical Dirichlet Processes
Teh, Y. W., Jordan, M. I., Beal, M. J., & Blei, D. M. (2006) · Journal of the American Statistical Association · doi:10.1198/016214506000000302 · Cited by 2,120
Cited by
Current state of melanoma diagnosis and treatment
Davis, L. E., Shalin, S. C., & Tackett, A. J. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1640032 · Cited by 922
“targeted therapies to treat each patient in a more personalized way based on the mutations they carry.(7,9,12-14)”
BackgroundMechanisms and prevention of UV‐induced melanoma
Sample, A., & He, Y. (2018) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/phpp.12329 · Cited by 372
Kugel, C. H., Douglass, S. M., Webster, M. R., Kaur, A., Liu, Q., Yin, X., Weiss, S. A., Darvishian, F., Al-Rohil, R. N., Ndoye, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1116 · Cited by 367
“Unfortunately, we were not able to account for somatic mutational load which has previously been shown to increase with age (42), and predict patient response to PD1 inhibition (20).”
BackgroundLucas, R. M., Yazar, S., Young, A. R., Norval, M., de Gruijl, F. R., Takizawa, Y., Rhodes, L. E., Sinclair, C. A., & Neale, R. E. (2019) · Photochemical & Photobiological Sciences · doi:10.1039/c8pp90060d · Cited by 233
Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures
Khan, N. H., Mir, M., Qian, L., Baloch, M., Ali Khan, M. F., Rehman, A.-U., Ngowi, E. E., Wu, D.-D., & Ji, X.-Y. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2021.06.014 · Cited by 234
“Patients with MCIR variants, display less shielding from UV by pheomelanin and carry the improved UV signature mutation burden [57,58].”
BackgroundPalmitoylation-dependent activation of MC1R prevents melanomagenesis
Chen, S., Zhu, B., Yin, C., Liu, W., Han, C., Chen, B., Liu, T., Li, X., Chen, X., Li, C., et al. (2017) · Nature · doi:10.1038/nature23887 · Cited by 234
Self-citationThe journey from melanocytes to melanoma
Centeno, P. P., Pavet, V., & Marais, R. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00565-7 · Cited by 197
Skin pigmentation and its control: from ultraviolet radiation to stem cells
Yardman‐Frank, J. M., & Fisher, D. E. (2021) · Experimental Dermatology · doi:10.1111/exd.14260 · Cited by 197
Causal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization?
Yarmolinsky, J., Wade, K. H., Richmond, R. C., Langdon, R. J., Bull, C. J., Tilling, K. M., Relton, C. L., Lewis, S. J., Davey Smith, G., & Martin, R. M. (2018) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-1177 · Cited by 194
“Such an analysis can be viewed as a MR appraisal of the effect of this sensitivity phenotype on somatic mutation burden in melanoma (161).”
BackgroundNRAS mutant melanoma: Towards better therapies
Randic, T., Kozar, I., Margue, C., Utikal, J. S., & Kreis, S. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102238 · Cited by 192
“have been associated with an increased risk of familial cutaneous melanoma [9-11].”
BackgroundImmune and molecular correlates in melanoma treated with immune checkpoint blockade
Byrne, E. H., & Fisher, D. E. (2017) · Cancer · doi:10.1002/cncr.30444 · Cited by 149
“In addition to the lack of dark UV-shielding eumelanin, these individuals have an increased risk of melanoma independent of UV exposure that is thought to be related to pro-oxidant roles of red/blond pheomelanin pigment,(66) and their melanomas have higher numbers of both UV-associated and non-UV–associated mutational…”
BackgroundG Protein‐Coupled receptors and heterotrimeric G proteins as cancer drivers
Arang, N., & Gutkind, J. S. (2020) · FEBS Letters · doi:10.1002/1873-3468.14017 · Cited by 157
Precancer Atlas to Drive Precision Prevention Trials
Spira, A., Yurgelun, M. B., Alexandrov, L., Rao, A., Bejar, R., Polyak, K., Giannakis, M., Shilatifard, A., Finn, O. J., Dhodapkar, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2346 · Cited by 129
“Disruptive germline polymorphisms in MC1R, contributor to phosphorylation of DNA repair proteins, have been associated with increased UV somatic mutation burden and skin cancer risk (130).”
BackgroundSelf-citationComparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
Newell, F., Johansson, P. A., Wilmott, J. S., Nones, K., Lakis, V., Pritchard, A. L., Lo, S., Rawson, R. V., Kazakoff, S. H., Colebatch, A. J., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0603 · Cited by 152
“mRNA kit ( n = 182) or the TruSeq RNA Library Prep Kit ( n = 48) and assembly with the gene, transcript , and exon features of the Ensembl (release 70) gene model after trimming for adapter sequences using Cutadapt (RRID:SCR_011841, version 1.11).”
InfluentialOstrowski, S. M., & Fisher, D. E. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2020.08.010 · Cited by 148
MC1R: Front and Center in the Bright Side of Dark Eumelanin and DNA Repair
Swope, V. B., & Abdel-Malek, Z. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092667 · Cited by 103
“Further support for the role of MC1R in determining the extent of UV-induced genotoxicity and mutagenesis came from a recent report that loss-of-function MC1R variants increase the risk of melanocytes to acquire UV signature mutations that promote malignant transformation to melanoma [82].”
BackgroundUltraviolet Radiation and Melanomagenesis: From Mechanism to Immunotherapy
Sun, X., Zhang, N., Yin, C., Zhu, B., & Li, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00951 · Cited by 124
“This study is the first to report the role of germline MC1R variants in influencing the somatic mutational landscape of melanoma from human data (57).”
BackgroundTargeting MC1R depalmitoylation to prevent melanomagenesis in redheads
Chen, S., Han, C., Miao, X., Li, X., Yin, C., Zou, J., Liu, M., Li, S., Stawski, L., Zhu, B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08691-3 · Cited by 89
Self-citationZocchi, L., Lontano, A., Merli, M., Dika, E., Nagore, E., Quaglino, P., Puig, S., & Ribero, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163760 · Cited by 99
Melanogenesis and the Targeted Therapy of Melanoma
Li, C., Kuai, L., Cui, R., & Miao, X. (2022) · Biomolecules · doi:10.3390/biom12121874 · Cited by 102
“In primary human melanocytes, the MC1R knockdown significantly impairs survival and DNA repair in response to UVR, hence increasing the risk of melanoma [54].”
BackgroundSelf-citationMC1R Functions, Expression, and Implications for Targeted Therapy
Guida, S., Guida, G., & Goding, C. R. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.06.018 · Cited by 86
Tagliabue, E., Gandini, S., Bellocco, R., Maisonneuve, P., Newton‐Bishop, J., Polsky, D., Lazovich, D., Kanetsky, P. A., Ghiorzo, P., Gruis, N. A., et al. (2018) · Cancer Management and Research · doi:10.2147/cmar.s155283 · Cited by 87
“Importantly, significant increases in the rate of non-C>T changes, some of which might depend on oxidative DNA damage, have also been found in R allele carriers compared with noncarriers.(53,54) Accordingly, associations of MC1R and genes frequently mutated in melanoma, such as BRAF or TERT, have been reported.”
ResultCurrent Molecular Markers of Melanoma and Treatment Targets
Yang, K., Oak, A. S. W., Slominski, R. M., Brożyna, A. A., & Slominski, A. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103535 · Cited by 89
Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling
Slominski, R. M., Kim, T., Janjetović, Z., Brożyna, A. A., Podgórska, E., Dixon, K. M., Mason, R. S., Tuckey, R. C., Sharma, R., Crossman, D. K., et al. (2024) · Cancers · doi:10.3390/cancers16122262 · Cited by 86
Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches
(IMI), F. T. I. M. I., Palmieri, G., Colombino, M., Casula, M., Manca, A., Mandalà, M., & Cossu, A. (2018) · Current Oncology Reports · doi:10.1007/s11912-018-0733-7 · Cited by 81
Germline Variants Impact Somatic Events during Tumorigenesis
Ramroop, J. R., Gerber, M. M., & Toland, A. E. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.04.005 · Cited by 74
“Melanomas from individuals with MC1Rvariants have a higher somatic mutational burden than individuals without MC1Rvariants.”
Genome-Wide Association Shows that Pigmentation Genes Play a Role in Skin Aging
Law, M. H., Medland, S. E., Zhu, G., Yazar, S., Viñuela, A., Wallace, L. M., Shekar, S. N., Duffy, D. L., Bataille, V. A., Glass, D., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.04.026 · Cited by 69
Yuan, T., Lu, Y., Edwards, K. L., Jakowatz, J. G., Meyskens, F. L., & Liu, F. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16060908 · Cited by 66
“For example, germline MC1R variants (loss of function) have been linked to melanomagenesis, and a major pathway is through altering melanin synthesis [34].”
BackgroundThe Making of a PreCancer Atlas: Promises, Challenges, and Opportunities
Srivastava, S., Ghosh, S., Kagan, J., Mazurchuk, R. V., Boja, E. S., Chuaqui, R. F., Chavarria-Johnson, E., Davidsen, T. M., Eary, J. F., Haim, T., et al. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.06.007 · Cited by 64
Pathophysiology of melanocortin receptors and their accessory proteins
Novoselova, T. V., Chan, L. F., & Clark, A. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.02.002 · Cited by 62
Cutaneous malignant melanoma and Parkinson disease: Common pathways?
Inzelberg, R., Flash, S., Friedman, E., & Azizi, E. (2016) · Annals of Neurology · doi:10.1002/ana.24802 · Cited by 52
“In individuals with the R allele, CMM tissue carries a high number of C>T mutations, a genomic signature linked to sun exposure, 42% (95% CI 5 15–76%) more than among persons without an R allele.(86) An MC1R variant (p.”
BackgroundSkin Pigmentation Genetics for the Clinic
Ainger, S. A., Jagirdar, K., Lee, K., Soyer, H. P., & Sturm, R. A. (2017) · Dermatology · doi:10.1159/000468538 · Cited by 57
Bellone, R. R., Liu, J., Petersen, J. L., Mack, M., Singer‐Berk, M., Drögemüller, C., Malvick, J., Wallner, B., Brem, G., Penedo, M. C. T., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30744 · Cited by 52
“People with MC1R mutations (red hair and freckling) are generally photosensitive, prone to sunburn when exposed to UV light, and have an increased risk of melanomas tied to UV associated somatic C>T transitions.(25) The gray coat color in horses is a gradual loss of pigment caused by a 4.”
BackgroundMelanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
Testa, U., Castelli, G., & Pelosi, E. (2017) · Medical Sciences · doi:10.3390/medsci5040028 · Cited by 60
Hernando, B., Dietzen, M., Parra, G., Gil‐Barrachina, M., Pitarch, G., Mahiques, L., Valcuende, F., McGranahan, N., & Martínez‐Cadenas, C. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.11.023 · Cited by 49
“Contrary to previous studies [13], no association, in univariate or multivariate analysis, was found between the somatic mutational load and the genotyp e in MC1R, a key pigmentation-related gene determining the ability to respond to UV exposure [ 14].”
ResultHerbert, K., Binet, R., Lambert, J.-P., Louphrasitthiphol, P., Kalkavan, H., Sesma-Sanz, L., Robles-Espinoza, C. D., Sarkar, S., Suer, E., Andrews, S., et al. (2019) · Genes & Development · doi:10.1101/gad.314633.118 · Cited by 45
“We added log 2 (FPKM+1) values for genes POU3F2 (BRN2, ENSG00000184486), POU4F1 (BRN3a, ENSG00000152192), and POU4F2 (BRN3b, ENSG00000151615) as variables to the negative binomial model previously published (Robles-Espinoza et al. 2016).”
Self-citationCui, Y., Miao, Y., Cao, L., Guo, L., Cui, Y., Yan, C., Zeng, Z., Xu, M., & Han, T. (2023) · Nature Communications · doi:10.1038/s41467-023-41101-3 · Cited by 45
Galván‐Femenía, I., Obón‐Santacana, M., Piñeyro, D., Guindo-Martínez, M., Duran, X., Carreras, A., Pluvinet, R., Velasco, J., Ramos, L., Aussó, S., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105437 · Cited by 48
Castejón-Griñán, M., Herráiz, C., Olivares, C., Jiménez‐Cervantes, C., & García-Borrón, J. C. (2018) · Oncogene · doi:10.1038/s41388-018-0216-1 · Cited by 44
Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention
Manganelli, M., Guida, S., Ferretta, A., Pellacani, G., Porcelli, L., Azzariti, A., & Guida, G. (2021) · Genes · doi:10.3390/genes12071093 · Cited by 41
“Intriguingly, C > T and non-C > T were the most common mutations observed across all MC1R genotypes [156,157].”
BackgroundTherapeutic targeting of protein S-acylation for the treatment of disease
Fraser, N. J., Howie, J., Wypijewski, K. J., & Fuller, W. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190707 · Cited by 33
“Several non-synonymous single nucleotide polymorphisms (SNPs) in the MC1R gene have been discovered, and a group of them termed red hair colour (RHC) variants are associated with red hair colour, fair skin and poor tanning ability as well as increased risk of developing melanoma [99-103].”
BackgroundJarrett, S. G., Carter, K. M., Bautista, R., He, D., Wang, C., & D'Orazio, J. A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003940 · Cited by 29
“Inherited dysfunction of the MC1R, a Gs protein-coupled receptor that signals through cAMP, is a bona fide melanoma risk factor (11, 13).”
BackgroundRetractedSomatic mutational profiles and germline polygenic risk scores in human cancer
Liu, Y., Gusev, A., Heng, Y. J., Alexandrov, L. B., & Kraft, P. L. (2022) · Genome Medicine · doi:10.1186/s13073-022-01016-y · Cited by 31
“For example, germline MC1R R alleles carrier status is significantly associated with somatic mutational burden in melanomas [17].”
BackgroundSelf-citationWang, S., Pitt, J. J., Zheng, Y., Yoshimatsu, T. F., Gao, G., Sanni, A., Oluwasola, O., Ajani, M., Fitzgerald, D., Odetunde, A., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32498 · Cited by 27
McMeniman, E., Duffy, D. L., Jagirdar, K., Lee, K., Peach, E., McInerney-Leo, A. M., De’Ambrosis, B., Rayner, J. E., Smithers, B. M., Soyer, H. P., et al. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18777 · Cited by 27
Schanknecht, E., Bachari, A., Nassar, N., Piva, T. J., & Mantri, N. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010859 · Cited by 30
Computational pharmacology profiling of borapetoside C against melanoma
Bhattacharya, K., Khanal, P., Patil, V. S., Dwivedi, P. S. R., Chanu, N. R., Chaudhary, R. K., Deka, S., & Chakraborty, A. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2213333 · Cited by 28
The MeLiM Minipig: An Original Spontaneous Model to Explore Cutaneous Melanoma Genetic Basis
Bourneuf, E. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00146 · Cited by 26
Pellegrini, C., Nardo, L. D., Cipolloni, G., Martorelli, C., Padova, M. D., Antonini, A., Maturo, M. G., Regno, L. D., Strafella, S., Micantonio, T., et al. (2017) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.10.002 · Cited by 25
Phenotypic and genotypic analysis of amelanotic and hypomelanotic melanoma patients
Rayner, J. E., McMeniman, E., Duffy, D. L., De’Ambrosis, B., Smithers, B. M., Jagirdar, K., Lee, K., Soyer, H. P., & Sturm, R. A. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15446 · Cited by 26
Rayner, J. E., Duffy, D. L., Smit, D. J., Jagirdar, K., Lee, K., De’Ambrosis, B., Smithers, B. M., McMeniman, E., McInerney-Leo, A. M., Schaider, H., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238529 · Cited by 25
Mutation load in melanoma is affected by MC 1R genotype
Johansson, P. A., Pritchard, A. L., Patch, A., Wilmott, J. S., Pearson, J. V., Waddell, N., Scolyer, R. A., Mann, G. J., & Hayward, N. K. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12571 · Cited by 22
Guo, J., Huang, J., Zhou, Y., Zhou, Y., Yu, L., Li, H., Hou, L., Zhu, L., Ge, D., Zeng, Y., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-4906-4 · Cited by 26
“For instance, the overall somatic mutational burden in melanoma is associated with germline MC1R status [17]; and in breast cancer it is associated with the germline RAD51B status (rs2588809) [18].”
BackgroundFunctional interplay between secreted ligands and receptors in melanoma
Herráiz, C., Jiménez‐Cervantes, C., Sánchez‐Laorden, B. L., & García-Borrón, J. C. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.06.021 · Cited by 23
Pellegrini, C., Botta, F., Massi, D., Martorelli, C., Facchetti, F., Gandini, S., Maisonneuve, P., Avril, M., Démenais, F., Paillerets, B. B., et al. (2019) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(19)30005-7 · Cited by 21
Synthetic lethality: emerging targets and opportunities in melanoma
Thompson, N., Adams, D. J., & Ranzani, M. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12573 · Cited by 22
“…please see the guidelines here EMAIL ALERTS Receive free email alerts and stay up-to-date on what is published in Pigment Cell & Melanoma Research – click here The official journal of INTERNATIONAL FEDERATION OF PIGMENT CELL SOCIETIES · SOCIETY FOR MELANOMA RESEARCH PIGMENT CELL & MELANOMA Research”
Self-citationcAMP-mediated regulation of melanocyte genomic instability: A melanoma-preventive strategy
Holcomb, N., Bautista, R., Jarrett, S. G., Carter, K. M., Krentz, M., & D'Orazio, J. A. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.10.008 · Cited by 22
Swope, V. B., Starner, R. J., Rauck, C., & Abdel‐Malek, Z. A. (2020) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12823 · Cited by 18
Chelakkot, V. S., Thomas, K., Romigh, T., Fong, A., Li, L., Ronen, S., Chen, S., Funchain, P., Ni, Y., & Arbesman, J. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00437-1 · Cited by 20
“Disruptive germline MC1R variants yielding poorly photo-protective pheomelanin 3,4 are associated with red hair and sun sensitivity and are major genetic determinants of cutaneous melanoma risk 5,6 .”
Self-citationMelanocortin-1 Receptor Expression as a Marker of Progression in Melanoma
Su, D. G., Djureinovic, D., Schoenfeld, D. A., Marquez-Nostra, B. V., Olino, K. L., Jilaveanu, L. B., & Kluger, H. M. (2024) · JCO Precision Oncology · doi:10.1200/po.23.00702 · Cited by 20
Tumor Mutational Burden Is Polygenic and Genetically Associated with Complex Traits and Diseases
Sun, X., Xue, A., Qi, T., Chen, D., Shi, D., Wu, Y., Zheng, Z., Zeng, J., & Yang, J. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3459 · Cited by 16
“Robles-Espinoza and colleagues found that germlineMC1R variants were associated with somatic mutation burden of melanoma (16).”
BackgroundDysregulation of MITF Leads to Transformation in MC1R-Defective Melanocytes
Lavelle, T. J., Alver, T. N., Heintz, K., Wernhoff, P., Nygaard, V., Nakken, S., Øy, G. F., Bøe, S. L., Urbanucci, A., & Hovig, E. J. (2020) · Cancers · doi:10.3390/cancers12071719 · Cited by 17
“It is also known that the germline variants of MC1R that inactivate or reduce the function of the receptor have been linked to an increased risk of developing melanoma, especially under UV exposure [8,59].”
BackgroundBautista, R., Carter, K. M., Jarrett, S. G., Napier, D. L., Wakamatsu, K., Ito, S., & D'Orazio, J. A. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12817 · Cited by 16
Castejón-Griñán, M., Cerdido, S., Sánchez-Beltrán, J., Lambertos, A., Abrisqueta, M., Herráiz, C., Jiménez‐Cervantes, C., & García-Borrón, J. C. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103135 · Cited by 14
“The MC1R genotype also influences the mutational load in melanoma, since carrying at least one RHC allele increases the burden of the UVR mutational signature as well as non-UVR base pair substitutions [20,21].”
BackgroundInherited MC 1R variants in patients with melanoma are associated with better survival in women
Lira, F. E., Podlipnik, S., Potrony, M., Tell‐Martí, G., Calbet‐Llopart, N., Barreiro, A., Carrera, C., Malvehy, J., & Puig, S. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18024 · Cited by 16
Jarrett, S. G., Carter, K. M., Shelton, B. J., & D’Orazio, J. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-12056-5 · Cited by 13
RetractedSomatic mutational signatures in polyposis and colorectal cancer
Grolleman, J. E., Díaz‐Gay, M., Franch‐Expósito, S., Castellví-Bel, S., & de Voer, R. M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.05.002 · Cited by 14
Genetics of Equine Ocular Disease
Bellone, R. R. (2020) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2020.03.009 · Cited by 13
Horrell, E. M. W., Jarrett, S. G., Carter, K. M., & D'Orazio, J. A. (2017) · Experimental Dermatology · doi:10.1111/exd.13291 · Cited by 11
Zanna, I., Caini, S., Raimondi, S., Saieva, C., Masala, G., Massi, D., Cocorocchio, E., Queirolo, P., Stanganelli, I., & Gandini, S. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23280 · Cited by 11
“Germline MC1R variants affect the mutational landscape of CM, especially increasing the frequency of UV‐induced C > T mutations (although non‐C > T mutations are also increased, possibly via oxidative DNA damage).(32,33) TERT promoter mutations are common in CM development (19%–41% in the three studies reviewed here,…”
BackgroundCell Death Modalities in Therapy of Melanoma
Wang, M., Zhao, J., Tang, M.-X., Li, M., Zhao, H., Li, Z., & Liu, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083475 · Cited by 11
Utility of histone H3K27me3 and H4K20me as diagnostic indicators of melanoma
Davis, L. E., Shalin, S. C., & Tackett, A. J. (2019) · Melanoma Research · doi:10.1097/cmr.0000000000000648 · Cited by 10
Hubert, J.-N., Suybeng, V., Vallée, M., Delhomme, T. M., Maubec, E., Boland, A., Bacq‐Daian, D., Deleuze, J., Jouenne, F., Brennan, P., et al. (2021) · Cancers · doi:10.3390/cancers13092243 · Cited by 10
“Both epidemiological and biochemistry studies documented a carcinogenic role of pheomelanins produced by functionally impaired receptor encoded by some MC1R allelic variants, considered as disruptive [15]: suspected underlying mechanisms included increased oxidative stress, inflammation, and immunomodulation [13], res…”
BackgroundDNA damage remodels the MITF interactome to increase melanoma genomic instability
Binet, R., Lambert, J., Tomková, M., Tischfield, S., Baggiolini, A., Picaud, S., Sarkar, S., Louphrasitthiphol, P., Dias, D., Carreira, S., et al. (2024) · Genes & Development · doi:10.1101/gad.350740.123 · Cited by 13
“Signaling downstream from MC1R can promote DNA damage repair (Swope et al. 2014; Robles-Espinoza et al. 2016) but can also increase MITF levels (Khaled et al. 2003), which may subsequently lead later to increased pigmentation (Malcov-Brog et al. 2018).”
BackgroundParacrine regulation of melanocyte genomic stability: a focus on nucleotide excision repair
Jarrett, S. G., Carter, K. M., & D'Orazio, J. A. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12582 · Cited by 10
“…interactions and by contact-independent means via secretion of growth factors and regulators that act in a paracrine manner on melanocytes through specific ligand–receptor interactions (Imokawa et al., 1992, 1997; Jamal and Schneider, 2002; Kadekaro et al., 2005; Rousseau et al., 2007).”
BackgroundWeiss, T. J., Crawford, E. R., Posada, V., Rahman, H., Liu, T., Murphy, B., Arnold, T. E., Gray, S., Hu, Z., Hennessey, R. C., et al. (2022) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13070 · Cited by 8
“…to melanoma formation is supported by evidence that melanomas from individuals with germline MC1R variants, who produce more pheomelanin, have higher levels of intrinsic ROS, and develop melanomas with a greater number of C>T transitions (Mitra et al., 2012; Robles-Espinoza et al., 2016).”
Advances in Chitosan-based Drug Delivery Systems in Melanoma: A Narrative Review
Dana, P. M., Hallajzadeh, J., Asemi, Z., Mansournia, M. A., & Yousefi, B. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230518143654 · Cited by 10
Single‐cell profiling of MC1R ‐inhibited melanocytes
Berns, H. M., Watkins‐Chow, D. E., Lu, S., Louphrasitthiphol, P., Zhang, T., Brown, K. M., Moura‐Alves, P., Goding, C. R., & Pavan, W. J. (2023) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13141 · Cited by 10
“These observations may partly explain why individuals with genetic RHC variants in MC1R exhibit an increased somatic mutational burden in melanocytes (Robles-Espinoza et al., 2016).”
BackgroundGermline Variants in Patients Affected by Both Uveal and Cutaneous Melanoma
Johansson, P. A., Palmer, J. M., McGrath, L. A., Warrier, S., Hamilton, H. R., Beckman, T. J., D'Mellow, M. G., Brooks, K. M., Glasson, W. J. H., Hayward, N. K., et al. (2024) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13199 · Cited by 8
Jarrett, S. G., & D'Orazio, J. A. (2016) · Photochemistry and Photobiology · doi:10.1111/php.12640 · Cited by 8
“Indeed, a recent study established a role for germline loss-of-function MC1R variants in increasing the somatic mutational landscape of melanoma (101).”
BackgroundGenetic Testing as a Tool to Identify Horses with or at Risk for Ocular Disorders
Bellone, R. R. (2017) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2017.08.005 · Cited by 8
TERT promoter mutations associate with MC 1R variants in melanoma patients
Nagore, E., Reyes-García, D., Heidenreich, B., García‐Casado, Z., Requena, C., & Kumar, R. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12567 · Cited by 8
“also been shown to be associated with an increase mutation burden in melanoma (Robles-Espinoza et al., 2016).”
BackgroundGermline genetic variants were interactively associated with somatic alterations in gastric cancer
Zhang, X., Wang, Y., Tian, T., Zhou, G., & Jin, G. (2018) · Cancer Medicine · doi:10.1002/cam4.1612 · Cited by 7
MC1R CpG island regulates MC1R expression and is methylated in a subset of melanoma tumours
Budden, T., & Bowden, N. A. (2018) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12739 · Cited by 7
Vergani, E., Frigerio, S., Dugo, M., Devecchi, A., Feltrin, E., Cecco, L. D., Vallacchi, V., Cossa, M., Guardo, L. D., Manoukian, S., et al. (2021) · Genes · doi:10.3390/genes12091440 · Cited by 7
“c MC1R genotype as previously reported [49].”
BackgroundDragani, T. A. (2020) · Human & Experimental Toxicology · doi:10.1177/0960327120911426 · Cited by 7
“For example, in melanoma, the mutation load was found to be higher in patients whose melanocortin 1 receptor gene had one or two R alleles (with genetic variants associated with red hair color and fair skin) than in patients with only r alleles.(32) Different individual exposures to cancer risk factors, and the differ…”
BackgroundRiquelme, I. L., García, S. M., Ordóñez, A. S., & Pilar, L. M. (2024) · International Journal of Dermatology · doi:10.1111/ijd.17602 · Cited by 5
“79,80 Other genes associated with hereditary cancer syndromes and not well-defined melanoma risk”
Cerdido, S., Sánchez-Beltrán, J., Lambertos, A., Abrisqueta, M., Padilla, L., Herráiz, C., Olivares, C., Jiménez‐Cervantes, C., & García-Borrón, J. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814381 · Cited by 5
Assessment of the Influence of UVR in Cutaneous Melanoma
Walker, G. J., & Khosrotehrani, K. (2025) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.70024 · Cited by 4
Kumar, R., Sood, P., Shaik, R., Singh, H. K., & Verma, A. (2023) · Journal for Research in Applied Sciences and Biotechnology · doi:10.55544/jrasb.2.4.5 · Cited by 5
“Reason being, the incidence of breast cancer is greater in developing nations than in developed ones[86].”
BackgroundNovedades dermatológicas en el diagnóstico histopatológico y nuevos tratamientos del melanoma
Puig, S. (2016) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2016.11.001 · Cited by 4
Lozano, A. C., Fuster, B. H., & Martínez‐Cadenas, C. (2019) · Àgora de salut · doi:10.6035/agorasalut.2019.6.7 · Cited by 3
Illueca, R. M., Rodríguez, G. H., Hernando, B., & Martínez‐Cadenas, C. (2020) · Àgora de salut · doi:10.6035/agorasalut.2020.7.23 · Cited by 3
Hernando, B., Swope, V. B., Guard, S. E., Starner, R. J., Choi, K., Anwar, A., Cassidy, P. B., Leachman, S. A., Kadekaro, A. L., Bennett, D. C., et al. (2018) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12732 · Cited by 3
Are Redheads at an Increased Risk of Melanoma?
Miao, X., Chen, S., Zhu, B., Yin, C., Li, X., Han, C., Cui, R., & Li, B. (2018) · Future Oncology · doi:10.2217/fon-2017-0525 · Cited by 3
“The idea that melanoma development in R allele carrying individuals is in part due to additional mutagenic processes is supported by these results [19].”
ResultSelf-citationBinet, R., Lambert, J., Tomková, M., Tischfield, S., Baggiolini, A., Picaud, S., Sarkar, S., Louphrasitthiphol, P., Dias, D., Carreira, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.21.537819 · Cited by 3
“Signalling downstream from MC1R can promote DDR (Swope et al. 2014; Robles-Espinoza et al. 2016), but can also increase MITF levels (Khaled et al. 2003)that may subsequently lead first to increased proliferation and later increased pigmentation (Malcov-Brog et al. 2018).”
BackgroundYang, M., Brage, S. E., Lapins, J., Grozman, V., Svedman, F. C., Höiom, V., & Helgadóttir, H. (2025) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.70050 · Cited by 2
“Germline MC1R variants, in particular the R alleles, have also been associated with higher tumor mutational burden (TMB) in primary melanoma tumors (Johansson et al. 2017; Robles-Espinoza et al. 2016).”
González, D. V., Lázaro‐Ochaita, P., Ribas, G., & Avilés-Izquierdo, J. A. (2023) · Experimental Dermatology · doi:10.1111/exd.14739 · Cited by 2
Roccuzzo, G., Giordano, S., Granato, T., Cavallo, F., Mastorino, L., Avallone, G., Pasini, B., Quaglino, P., & Ribero, S. (2023) · Cancers · doi:10.3390/cancers15153772 · Cited by 2
Villa-González, J. M., Revilla, S. C., Lombardero, L., & García, J. G. (2024) · Clinical and Experimental Dermatology · doi:10.1093/ced/llae221 · Cited by 2
Metadata
- Authors
- Robles-Espinoza, C. D., Roberts, N. D., Chen, S., Leacy, F. P., Alexandrov, L. B., Pornputtapong, N., Halaban, R., Krauthammer, M., Cui, R., Timothy Bishop, D., & Adams, D. J.
- Affiliations
- Wellcome Sanger Institute (GB)
- Boston University (US)
- Royal College of Surgeons in Ireland (IE)
- Yale University (US)
- Corresponding author
- Adams, David J.
- ORCID
- Venue
- Nature Communications
- Published
- 2016-07-12
- Volume
- 7
- Issue
- 1
- Pages
- 12064-12064
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4945874
- OpenAlex
- W2474228978
- Cited by
- 124
- References
- 48
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 11 · 2023: 15 · 2022: 5 · 2021: 10 · 2020: 15 · 2019: 20 · 2018: 18 · 2017: 18 · 2016: 5
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Yale University (P50 CA121974)
- Wellcome Trust
- Cancer Research UK (13031, 10589, 19167)
- National Institutes of Health (UL1TR001863)
- National Cancer Institute (P50CA121974)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- MC1R, germline mutations, somatic mutation burden, cutaneous melanoma, sun exposure, mutational signatures, C>T mutations, melanoma risk
- MeSH terms
- Mutation Accumulation, Aged, Alleles, Female, Hair Color, Head and Neck Neoplasms, Humans, Male, Melanoma, Melanosis, Middle Aged, Mutation, Neoplasm Invasiveness, Skin Neoplasms, Skin Pigmentation, Genetic Variation, Cohort Studies, Germ-Line Mutation, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Receptor, Melanocortin, Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.